BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37508201)

  • 1. Relationship between COVID-19 and ICU-Acquired Bloodstream Infections Related to Multidrug-Resistant Bacteria.
    Piantoni A; Houard M; Piga G; Zebian G; Ruffier des Aimes S; Holik B; Wallet F; Rouzé A; Kreitmann L; Loiez C; Labreuche J; Nseir S
    Antibiotics (Basel); 2023 Jun; 12(7):. PubMed ID: 37508201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Acquisition of Multidrug-Resistant Bacteria in Patients Admitted to COVID-19 Intensive Care Units: A Monocentric Retrospective Case Control Study.
    Bogossian EG; Taccone FS; Izzi A; Yin N; Garufi A; Hublet S; Njimi H; Ego A; Gorham J; Byl B; Brasseur A; Hites M; Vincent JL; Creteur J; Grimaldi D
    Microorganisms; 2020 Nov; 8(11):. PubMed ID: 33227956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colonization pressure as a risk factor of ICU-acquired multidrug resistant bacteria: a prospective observational study.
    Masse J; Elkalioubie A; Blazejewski C; Ledoux G; Wallet F; Poissy J; Preau S; Nseir S
    Eur J Clin Microbiol Infect Dis; 2017 May; 36(5):797-805. PubMed ID: 28000030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of colonization with multidrug-resistant bacteria on the risk of ventilator-associated pneumonia in septic shock.
    Bredin S; Charpentier J; Mira JP; Gastli N; Pène F; Llitjos JF
    J Crit Care; 2022 Oct; 71():154068. PubMed ID: 35636346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunosuppression at ICU admission is not associated with a higher incidence of ICU-acquired bacterial bloodstream infections: the COCONUT study.
    Zebian G; Kreitmann L; Houard M; Piantoni A; Piga G; Ruffier des Aimes S; Holik B; Wallet F; Labreuche J; Nseir S
    Ann Intensive Care; 2024 Jun; 14(1):83. PubMed ID: 38837065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bloodstream infections in critically ill patients with COVID-19.
    Giacobbe DR; Battaglini D; Ball L; Brunetti I; Bruzzone B; Codda G; Crea F; De Maria A; Dentone C; Di Biagio A; Icardi G; Magnasco L; Marchese A; Mikulska M; Orsi A; Patroniti N; Robba C; Signori A; Taramasso L; Vena A; Pelosi P; Bassetti M
    Eur J Clin Invest; 2020 Oct; 50(10):e13319. PubMed ID: 32535894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-body-site colonization screening cultures for predicting multi-drug resistant Gram-negative and Gram-positive bacteremia in hematological patients.
    Torres I; Huntley D; Tormo M; Calabuig M; Hernández-Boluda JC; Terol MJ; Carretero C; de Michelena P; Pérez A; Piñana JL; Colomina J; Solano C; Navarro D
    BMC Infect Dis; 2022 Feb; 22(1):172. PubMed ID: 35189833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics and prognosis of bloodstream infection in patients with COVID-19 admitted in the ICU: an ancillary study of the COVID-ICU study.
    Massart N; Maxime V; Fillatre P; Razazi K; Ferré A; Moine P; Legay F; Voiriot G; Amara M; Santi F; Nseir S; Marque-Juillet S; Bounab R; Barbarot N; Bruneel F; Luyt CE;
    Ann Intensive Care; 2021 Dec; 11(1):183. PubMed ID: 34952960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidrug-resistant Acinetobacter baumannii infections in COVID-19 patients hospitalized in intensive care unit.
    Russo A; Gavaruzzi F; Ceccarelli G; Borrazzo C; Oliva A; Alessandri F; Magnanimi E; Pugliese F; Venditti M
    Infection; 2022 Feb; 50(1):83-92. PubMed ID: 34176088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ventilator-associated pneumonia in patients with cancer: Impact of multidrug resistant bacteria.
    Cornejo-Juárez P; González-Oros I; Mota-Castañeda P; Vilar-Compte D; Volkow-Fernández P
    World J Crit Care Med; 2020 Aug; 9(3):43-53. PubMed ID: 32844090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Multidrug-Resistant Bacteria and Mortality in Critically Ill Patients.
    Duclos G; Lakbar I; Boucekine M; Lolo G; Cassir N; Leone M
    Adv Ther; 2023 Apr; 40(4):1736-1749. PubMed ID: 36811794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bloodstream Infections in a COVID-19 Non-ICU Department: Microbial Epidemiology, Resistance Profiles and Comparative Analysis of Risk Factors and Patients' Outcome.
    Giannitsioti E; Louka C; Mamali V; Kousouli E; Velentza L; Papadouli V; Loizos G; Mavroudis P; Kranidiotis G; Rekleiti N; Stamati A; Speggos I; Daniil I; Kouvatsos P; Sidiropoulou C; Linardaki G; Gerakari S; Chrysos G; Themeli-Digalaki K; Zarkotou O
    Microorganisms; 2022 Jun; 10(7):. PubMed ID: 35889033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alarming Upward Trend in Multidrug-Resistant Bacteria in a Large Cohort of Immunocompromised Children: A Four-Year Comparative Study.
    Mihalcea AR; Garnier N; Faure-Conter C; Rama N; Renard C; Benezech S; Bertrand Y; Fuhrmann C; Domenech C
    Cancers (Basel); 2023 Feb; 15(3):. PubMed ID: 36765895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 increased the risk of ICU-acquired bloodstream infections: a case-cohort study from the multicentric OUTCOMEREA network.
    Buetti N; Ruckly S; de Montmollin E; Reignier J; Terzi N; Cohen Y; Siami S; Dupuis C; Timsit JF
    Intensive Care Med; 2021 Feb; 47(2):180-187. PubMed ID: 33506379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensive-care-unit-acquired bloodstream infections in a regional critically ill population.
    Laupland KB; Kirkpatrick AW; Church DL; Ross T; Gregson DB
    J Hosp Infect; 2004 Oct; 58(2):137-45. PubMed ID: 15474185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary Infections in Critical Patients with COVID-19 Associated ARDS in the ICU: Frequency, Microbiologic Characteristics and Risk Factors.
    Taysi MR; Yildirim F; Simsek M; Dural HI; Sencan I
    J Coll Physicians Surg Pak; 2023 Feb; 33(2):181-187. PubMed ID: 36797628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial bloodstream infection in critically ill patients with COVID-19: a retrospective cohort study.
    Bartoszewicz M; Czaban SL; Bartoszewicz K; Kuźmiuk D; Ładny JR
    Ther Adv Infect Dis; 2023; 10():20499361231207178. PubMed ID: 37869469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective comparative analysis of risk factors and outcomes in patients with carbapenem-resistant
    Niu T; Xiao T; Guo L; Yu W; Chen Y; Zheng B; Huang C; Yu X; Xiao Y
    Infect Drug Resist; 2018; 11():2021-2030. PubMed ID: 30464544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laboratory confirmed bloodstream infection aetiology in an intensive care unit: eight years study.
    Orsi GB; Franchi C; Marrone R; Giordano A; Rocco M; Venditti M
    Ann Ig; 2012; 24(4):269-78. PubMed ID: 22913170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nosocomial bloodstream infections in ICU and non-ICU patients.
    Suljagić V; Cobeljić M; Janković S; Mirović V; Marković-Denić L; Romić P; Mikić D
    Am J Infect Control; 2005 Aug; 33(6):333-40. PubMed ID: 16061139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.